In the beginning of 2018, Taiwan’s Ministry of Science and Technology (MOST) initiated a five-year "Artificial Intelligence (AI) Innovation Research Center Program" to promote R&D and applications of AI from Taiwan. In this program, four AI centers are founded at four top-notch universities, including the one at National Taiwan Universities called MOST Joint Research Center for AI Technology and All Vista Healthcare, which is composed of two sub-centers, the Artificial Intelligence Technology sub-center and the All Vista Healthcare sub-center.

The All Vista Healthcare Center (a.k.a. MAHC) aims to establish a world level platform to boost AI-application-oriented data and technology exploration, through which any technology targeted for specific AI application can be quickly developed and validated. This sub-center is expected to lead domestic research teams specialized in Bio and Medicine to advance the current level of domestic medicine, and in turn to improve the health and well-being of our fellow people. Another aim of the sub-center is to build up a critical cluster of bio and medical research integrated with AI, so that our substantial domestic medical achievements enhanced by AI techniques can be more easily recognized worldwide.

Courses: (1) Drug Delivery Systems (Topics: 1. Ethics and Regulatory considerations for Drug Delivery systems; 2. Nanotechnology in Drug Delivery and Medical Imaging/ Injectable Drug Delivery System); (2) Biomaterials; (3) Regenerative Medicine

- Manage new drug development projects, mainly involved in topical drug development.
- Provide scientific background including disease mechanism and treatment
- Communicate with clinical physicians of the field for the needs of the product.
- Manage scope, timeline, budget, quality, resource element, and milestone achievement.
- Track and communicate data with functional teams in CMC, nonclinical, and clinical studies
- Preparation of filing documents for regulatory submissions or meetings per ICH requirements.
- Provide scientific opinions and supports for literature search for all new drug development projects
- Support administrative tasks including meeting and agreement management.

- Developed and characterized lipid-based biomimetic devices as an application for therapeutics and diagnostics, specifically for cancer treatment and cancer cell detection.
- Developed model systems to study interactions between biomarkers and cell surface in order to identify specific biomolecular interactions responsible for cellular processes.

- Developed and characterized drug delivery devices based on osmotic technologies, tasks involved in tablet compression, capsule coating, assembly of delivery device, and drug release and dissolution.

- Developed and characterized drug formulation including complex solution and nanosuspension.